Study Research Protocol for Phenome India-CSIR Health Cohort Knowledgebase (PI-CHeCK): A Prospective multi-modal follow-up study on a nationwide employee cohort

Phenome India Consortium; Shantanu Sengupta

doi:10.1101/2024.10.17.24315252

Abstract

The ability to predict the health trajectories of individuals based on their personalized risk scores can help formulate a preventive roadmap - of a disease or its complications. Currently, most of these risk prediction algorithms are based on epidemiological data from the Caucasian population and there is liberal evidence that they fail to work well for the Indian population due to ethnic diversity, varied dietary and lifestyle patterns, and altered risk profiles. In this multi-centric pan-India study, we aim to address these challenges and develop clinically relevant personalized risk prediction scores of cardio-metabolic diseases for the Indian population. This multi-centric program will involve the longitudinal collection and bio-banking of samples from ∼10,000 CSIR employees, pensioners, and their spouses of which of the baseline sample collection is now completed. Multi-parametric data collected during baseline sampling includes a clinical questionnaire, lifestyle and dietary habits, anthropometric parameters, assessment for lung function, liver elastography, ECG, biochemical data, followed by molecular assays, including genomics, plasma proteomics, metabolomics, and fecal microbiome. In addition to mining the data for associations between the different parameters and their cardio-metabolic outcomes, we intend to develop models using artificial intelligence algorithms (AI) to predict phenotypic conditions. The study may be a step towards precision medicine for the Indian population, especially middle-income group strata, and aid in refining the normative values of healthy/disease parameters in the Indian population.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The study is funded by CSIR through grant HCP47.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by IHEC at Institute of Genomics and Integrative Biology (reference no.: CSIR-IGIB/IHEC/2023-24/16). Centre for Cellular and Molecular Biology (IEC95-R1/2023). The study was registered vide CTRI number- CTRI/2024/01/061807 .

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes